Benzinga's Microcap Movers for Monday July 16, 2012

Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:

Shares of Portlogic Systems (

), the Toronto, ON mobile phone software company, rose 79.01% Monday on 12 times average volume. Portlogic Systems announced Monday it has appointed Mr. Joe Putegnat as CEO. Mr. Putegnat most recently founded and served as President of XcomIP. Mr. Putegnat also founded and served as CEO of Xchangetel, a privately held international long-distance wholesale carrier focused on the use of VoIP technologies, which was acquired by MicroHoldings US. Prior to that, Mr. Putegnat founded and served as President and CEO of Jupiter Telecom, an international long-distance wholesale carrier focused on the use of VoIP technologies in the early years of integration. Prior to founding Jupiter Telecom, Mr. Putegnat was founder and President of LDExchange.com, a technology-oriented long-distance wholesale carrier, which he built to more than $80 million in annual revenues with 220 carriers connected to the network. Portlogic Systems closed at $0.14 on Monday.

Anthera Pharmaceuticals

, the Hayward, CA biopharmaceutical company, rose 87.24% Monday on 19 times average volume. Anthera Pharmaceuticals announced Monday the final set of clinical data from the Phase 2b PEARL-SC study in patients with systemic lupus erythematosus. Final data from the PEARL-SC clinical study with 200mg weekly blisibimod suggest sustained and greater treatment effects versus placebo utilizing 6, 7, and 8-point improvements in the SELENA-SLEDAI disease-scoring index. In the predefined population of patients with severe disease who were also taking corticosteroids, the SRI-8 treatment benefit in the 200mg weekly blisibimod cohort was seen as early as week eight and achieved statistical significance starting at week 16 (35.4% blisibimod response versus 17.0% placebo response, p=0.04) through the 24 week endpoint (41.7% blisibimod response versus 10.4% placebo response, p<0.001). Anthera Pharmaceuticals closed at $1.33 on Monday.

Shares of iBio

, the Newark, DE biotechnology company, rose 31.25% Monday on 3 times average volume. iBio was the subject of a

article on Monday. iBio closed at $1.05 on Monday.